BENEDETTI, PIETRO
 Distribuzione geografica
Continente #
NA - Nord America 2.115
EU - Europa 382
AS - Asia 253
Totale 2.750
Nazione #
US - Stati Uniti d'America 2.113
IT - Italia 147
SG - Singapore 107
CN - Cina 92
UA - Ucraina 73
FI - Finlandia 46
DE - Germania 44
IN - India 35
SE - Svezia 29
GB - Regno Unito 20
FR - Francia 17
VN - Vietnam 14
NL - Olanda 3
CA - Canada 2
IE - Irlanda 2
OM - Oman 2
BD - Bangladesh 1
DK - Danimarca 1
ID - Indonesia 1
JP - Giappone 1
Totale 2.750
Città #
Fairfield 289
Jacksonville 269
Woodbridge 177
Ashburn 144
Houston 144
Chandler 128
Ann Arbor 123
Wilmington 107
Cambridge 106
Seattle 106
Singapore 92
Princeton 86
Santa Clara 61
Boardman 57
Padova 38
San Diego 26
Des Moines 22
Beijing 21
Roxbury 19
Nanjing 17
Milan 16
Dong Ket 14
Helsinki 12
Medford 10
Guangzhou 8
Rome 8
Jiaxing 6
Shenyang 6
St Louis 6
Falls Church 5
Naples 5
Norwalk 5
Asiago 4
Catania 3
Hebei 3
New York 3
Piemonte 3
Redwood City 3
Changsha 2
Chiswick 2
Dallas 2
Dublin 2
Este 2
Indiana 2
London 2
Martellago 2
Nanchang 2
Savigliano 2
Tappahannock 2
Vicenza 2
Villa Castelli 2
Chiampo 1
Copenhagen 1
Dhaka 1
Galliate 1
Haikou 1
Hounslow 1
Kharkiv 1
Muscat 1
Ningbo 1
Ottawa 1
Pavia 1
Perugia 1
Piazzola Sul Brenta 1
Rockville 1
San Francisco 1
San Mateo 1
Semarang 1
Tianjin 1
Tokyo 1
Treviso 1
Zhengzhou 1
Totale 2.199
Nome #
Disulfide cross-links reveal conserved features of DNA topoisomerase I architecture and a role for the n terminus in clamp closure 159
Biologia Molecolare terza edizione 135
A single mutation in the 729 residue modulates human DNA topoisomerase IB DNA binding and drug resistance. 132
Production of bioethanol under high pressure of CO2: The effect of process conditions 132
Mechanisms regulating cellular responses to DNA topoisomerase I-targeted agents 119
Thr729 in human topoisomerase I modulates anti-cancer drug resistance by altering protein domain communications as suggested by molecular dynamics simulations 117
null 110
Alterations in linker flexibility suppress DNA topoisomerase I mutant-induced cell lethality 99
Study of Yeast DNA Topoisomerase II and Its Truncation Derivatives by Transmission Electron Microscopy 96
Locking the DNA topoisomerase I protein clamp inhibits DNA rotation and induces cell lethality 92
Comparative mutational analysis of wild-type and stretched tRNALeu3 gene promoters. 91
Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain 85
The Deubiquitinating Enzyme Doa4p Protects Cells from DNA Topoisomerase I Poisons 79
Effect on DNA relaxation of the single Thr718Ala mutation in human topoisomerase I: a functional and molecular dynamics study 79
Purification and characterization of Xenopus laevis topoisomerase II. 78
Holoenzyme assembly and ATP-mediated conformational dynamics of topoisomerase VI 77
The Use of Yeast and Yeast Strains Expressing Human DNA Topoisomerases in the Study of Anticancer Drugs. Drug Resistance as a Biochemical Target in Cancer Chemiotherapy (T.Tsuruo, M. Ogawa and S.K. Carter, eds) Academic Press, San Diego CA 75
Drug-induced stabilization of covalent DNA topoisomerase I-DNA intermediates. DNA cleavage assays 74
Yeast as a model organism for studying the actions of DNA topoisomerase-targeted drugs. 71
Visualization of DNA Topoisomerases by Electron Microscopy. 65
Artemisinin Derivatives with Antimelanoma Activity Show Inhibitory Effect against Human DNA Topoisomerase 1 61
Separation of RNA transcription and processing activities from Xenopus laevis. . 60
Domain Interactions Affecting Human DNA Topoisomerase I Catalysis and Camptothecin Sensitivity. Molecular Phamacology 56:1105-1115 (1999). 58
Molecular Dissection of a Protein SopB Essential for E.coli F Plasmid Partition. 57
Yeast Saccharomyces cerevisiae as a model system to study the cytotoxic activity of the antitumor drug camptothecin. 57
Protein concerted motions in the DNA-Human Topoisomerase I complex 55
tecniche e metodi per la biologia molecolare 54
Spontaneous Formation of Topoisomerase II Multimers in vitro: Effects of Metals, b-Gycerophosphate and Phosphorylation of its C-Terminal Domain 52
Template Supercoiling by a Yeast GAL4 Protein-Phage T7 RNA Polymerase Chimera. Science (1990) 249: 1261-1265 47
Expression of Human DNA Topoisomerase I in Yeast Cells Lacking Yeast Topoisomerase I: Restoration of Sensitivity of the Cells to the Antitumor Drug Campothecin. 46
Single mutation in the linker domain confers protein flexibility and camptothecin resistance to human topoisomerase I J. Biol. Chem., Aug 2003 42
Analysis of Camptothecin resistance in yeast: relevance to cancer therapy. 35
In vitro catenation and decatenation of DNA and a novel ATP-dependent topoisomerase. 34
Increased camptothecin toxicity in mammalian cells expressing Saccharomyces cerevisiae DNA topoisomerase I. 32
Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine. 30
Il racconto delle origini. Dal Big bang alla vita. 26
RNA: una molecola per tutte le stagioni 21
Solution structures of 2x6-meric and 4x6-meric hemocyanins of crustaceans Carcinus aestuarii, Squilla mantis and Upogebia pusilla. 20
Viruses responsible for emerging deseases in south- east asia 17
Totale 2.769
Categoria #
all - tutte 8.558
article - articoli 7.014
book - libri 570
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 974
Totale 17.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020444 0 0 0 0 59 53 42 67 51 51 85 36
2020/2021491 9 36 12 58 86 38 10 42 74 28 63 35
2021/2022411 11 55 41 34 24 15 32 43 25 6 51 74
2022/2023331 79 36 15 19 52 45 3 24 32 1 14 11
2023/2024152 17 20 31 12 8 4 0 4 2 5 27 22
2024/2025280 3 119 33 43 82 0 0 0 0 0 0 0
Totale 2.769